Substance misuse has been on the rise, and COVID-19 has only amplified the problem. Many of the substance use behaviors amplified during the pandemic have become the damaging habits and addictions of today, negatively impacting health and interrupting pathways to wellness.

The stigma surrounding addiction and substance use disorders in the U.S. contributes to a health equity gap that costs $232 billion in health care costs annually. Which populations have seen the deepest impact when it comes to substance use disorders, and what does it mean for employers, public health and individuals?

Dr. Yusuf Sherwani will address the importance of destigmatization plus issues of access, care quality and health equity on the journey to corporate and individual wellness. Attendees will gain a deeper understanding of the cost of addiction and the shortcomings of traditional treatment approaches with proven strategies to help them combat and overcome addiction in their organizations.
Following this webinar, you will be able to:

• Appreciate the importance of destigmatizing addiction, and understand that substance use disorders are not a moral failing or character flaw, but a chronic disease that can be managed with medical treatment.
• Comprehend the scope and impact of substance use disorders on public and societal health; learn about overcoming barriers to access quality care; and see why addiction is one of the most significant drivers of medical spend in the corporate world.
• Understand that traditional treatment pathways aren’t working, and learn about the role of medication assisted treatment in providing effective, accessible, holistic treatment for substance use disorders.